(Q46354712)

English

Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase

scientific article published in January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

maternal health

0 references

Factor V Leiden

1 reference

based on heuristic

inferred from title

author name string

J Rigó

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

B Nagy

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

L Fintor

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

J Tanyi

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

A Beke

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

I Karádi

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

Z Papp

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

Hypertension in Pregnancy

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

19

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

163-172

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Resistance to activated protein C as a basis for venous thrombosis.

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

The factor V Leiden mutation may predispose women to severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Extensive hepatic infarction caused by thrombosis of right portal vein branches and arterial vasospasm in HELLP syndrome associated with homozygous factor V Leiden

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Activated protein C resistance in normal pregnancy

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Activated protein C resistance and adverse pregnancy outcome

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Elevated homocyst(e)ine levels with preeclampsia

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Placental thrombosis and second trimester miscarriage in association with activated protein C resistance

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

HELLP syndrome associated with factor V R506Q mutation

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Activated protein C resistance and Factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome

1 reference

https://api.crossref.org/works/10.1081%2FPRG-100100132

21 January 2018

Identifiers

10.1081/PRG-100100132

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/10877984

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46354712&oldid=2107548428"